Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial electron transport chain (ETC) and cellular ATP synthesis pathways, collectively known as oxidative phosphorylation (OXPHOS), are the primary energy-generating systems in eukaryotic cells [1]. Located in the inner mitochondrial membrane, the ETC consists of four multi-protein complexes (I-IV) and two mobile electron carriers (ubiquinone and cytochrome c) that facilitate the transfer of electrons from NADH and FADH2 to molecular oxygen [2]. This process creates a proton gradient across the membrane, which drives ATP synthase (Complex V) to produce ATP from ADP and inorganic phosphate [1]. Beyond energy production, these pathways are critical for maintaining cellular redox balance and regulating apoptosis through the release of cytochrome c [4]. Dysregulation of these pathways is central to various pathologies, including primary mitochondrial diseases like Leigh syndrome, neurodegenerative disorders such as Parkinson's disease, and metabolic syndromes [5]. In oncology, certain cancers exhibit a dependency on OXPHOS for survival and resistance to therapy, leading to the development of inhibitors like IACS-010759 [4]. However, because these pathways are essential for the function of almost all tissues, particularly the heart and brain, targeting them requires high specificity to avoid systemic toxicity and life-threatening lactic acidosis [3].
Inhibition of electron transfer within mitochondrial complexes I-IV or inhibition of ATP synthase (Complex V), leading to the disruption of the proton motive force and reduction in cellular ATP production.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial electron transport chain and cellular ATP synthesis pathways (ETC/OXPHOS).